9 chapters across the catalog
Ivermectin Efficacy Against Hantavirus and Vaccine Development
The hosts discuss the potential use of Ivermectin for Hantavirus, noting it is an RNA virus. Dr. Scott Gottlieb dismissed the treatment on television, arguing the drug's mechanism does not work against this specific virus, while the hosts point out that 15 different Hantavirus vaccines are currently in development by various military and health agencies.
RNA Vaccine Development, Safety Risks and Indemnification
The development of RNA vaccines by companies like Moderna and CureVac offered a potential path to beating the traditional 18-month timeline for vaccine creation. Experts noted the difficulty of ensuring efficacy in elderly populations and the risks of side effects when deployed at a global scale. Bill Gates mentioned that governments would need to provide risk indemnification before a vaccine could be distributed to the entire world.
The concept of memory being encoded in RNA is discussed alongside the announcement of EU vaccine passports. Chancellor Angela Merkel indicated that vaccination certificates would likely be ready by summer to facilitate travel between member states.
Viral Mutation Mechanics, Annual Vaccine Requirements, Lockdown Justifications
Sanjay Gupta explains the mechanics of RNA virus mutations, noting that while they are often mundane, they can lead to the necessity of annual vaccinations. There is skepticism regarding whether the "new variant" narrative is being leveraged by politicians to justify continued lockdowns or to secure municipal bailouts through stimulus relief bills. Despite travel bans, officials admit the strain likely already exists within the United States.
Bill Gates, RNA Vaccines and Elderly Risk Factors
Bill Gates promotes the development of RNA vaccines, such as those from Moderna, as the primary solution to the pandemic. However, Gates admits that vaccines are often ineffective in the elderly due to their weakened immune systems. The hosts discuss the risks of "amping up" vaccines with adjuvants and the legal indemnification governments must provide to manufacturers.
Plandemic Documentary, Dr. Judy Mikovits and mRNA Vaccines
The "Plandemic" documentary featuring Dr. Judy Mikovits has sparked a wave of coordinated debunking efforts. A key point of contention is the distinction between traditional RNA virus vaccines and experimental mRNA vaccines, which have never been proven to work in humans. While debunkers claim RNA vaccines are common, critics argue they are conflating old-fashioned attenuated vaccines with the new genetic technology being proposed for COVID-19.
Bill Gates appeared on BBC Breakfast to advocate for a globalized response to the coronavirus pandemic, asserting that a vaccine for seven billion people is the only path back to normalcy. Critics argue that Gates is positioning himself as a health expert despite lacking a medical degree and is pushing for global governance and manufacturing dependencies on China and India.
Bill Gates discussed the challenges of developing an RNA vaccine for the global population, noting that safety testing at such a scale is unprecedented. Gates emphasized that governments must provide legal indemnification for manufacturers before a vaccine can be widely distributed.
The hosts revisit a JPMorgan Chase report highlighting the pharmaceutical industry's shift toward vaccines as a primary profit center. They discuss the legal indemnification of vaccine makers and the experimental nature of RNA vaccines. Curry notes that these new treatments involve gene splicing and have never been proven to work in a traditional sense.
